Furthermore, the biomarkers of ossification (RUNX2, OC, AP, OPG, and RANKL) and the biomarkers of mesenchymal growth (bFGF and CTGF) were much stronger in BPOP than in osteochondroma. The gene discussed is RUNX2; the disease is Osteochondroma.